Cutera, Inc. (NASDAQ:CUTR)
CAPS Rating:
Designs, develops, manufactures and markets the CoolGlide, Xeo and Solera product platforms for use by dermatologists, plastic surgeons, gynecologists and other qualified practitioners to offer safe, effective and non-invasive aesthetic treatments.
RSS Headlines
Fool UK
Recs
CUTR had been a consistent performer until it was sued for patent infringement by PMTI. It has now settled that suit and should resume its growth.
CUTR is in a good position to profit from the aging of the baby boomers. It offers cosmetic improvements that are less invasive and expensive than cosmetic surgery.